| payload |
{"created_at":"2026-04-16T22:05:27.087 {"created_at":"2026-04-16T22:05:27.087014+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVG8zNlN4QkpHWURLZF9LX3V6cDY2VEdoZE5SNlV6RjU1OWxsNGNVQWZUVW5UMUpkNGFGWHRMN1lZb2xtRkpVaTV6T0YxXzhwWkhPcFFqU3k0R29qN3FhUmVRZnUwWG9INU1VdFBRWmVjclR0OUh2eEdQUEdYZThCcUNLTlFNZjNjem91Y05iVHBsSWVIVEFBdzhTMlRZZG5iN3ltTDBhUUNZQ2M?oc=5","value":{"fp":"072865d270241739","published_at":"2026-04-16T15:36:22+00:00","source":"Fierce Pharma","source_domain":"fiercepharma.com","source_url":"https://www.fiercepharma.com","summary":"'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again Fierce Pharma Analysis of Alzheimer\u2019s Drugs Stirs Debate About Their Effectiveness The New York Times Cochrane review reignites Alzheimer\u2019s amyloid wars statnews.com Effect of \u2018gamechanger\u2019 Alzheimer\u2019s drugs \u2018trivial\u2019, review concludes The Guardian 'Breakthrough' Alzheimer's drugs unlikely to benefit patients, report suggests BBC","title":"'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again - Fierce Pharma","url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPVG8zNlN4QkpHWURLZF9LX3V6cDY2VEdoZE5SNlV6RjU1OWxsNGNVQWZUVW5UMUpkNGFGWHRMN1lZb2xtRkpVaTV6T0YxXzhwWkhPcFFqU3k0R29qN3FhUmVRZnUwWG9INU1VdFBRWmVjclR0OUh2eEdQUEdYZThCcUNLTlFNZjNjem91Y05iVHBsSWVIVEFBdzhTMlRZZG5iN3ltTDBhUUNZQ2M?oc=5"}}... |